Literature DB >> 20338147

Multidrug- and extensively drug-resistant tuberculosis: a persistent problem in the European Union European Union and European Economic Area.

C Ködmön1, V Hollo, E Huitric, A Amato-Gauci, D Manissero.   

Abstract

Since 2008, the European Centre for Disease Prevention and Control has been collecting data from the European Union (EU) and European Economic Area (EEA) on resistance to first- and second-line drugs against tuberculosis (TB). In 2008, the proportion of multidrug-resistant tuberculosis (MDR TB) was 6.0% of the total case load for 25 countries reporting data. Extensively drug-resistant (XDR TB) reporting has increased since 2007 and was observed in 7.3% of the MDR TB cases in 13 reporting countries. MDR TB remains a threat and XDR TB is now established within the EU/EEA borders.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20338147

Source DB:  PubMed          Journal:  Euro Surveill        ISSN： 1025-496X


  6 in total

1.  Multidrug and extensively drug-resistant tuberculosis from a general practice perspective.

Authors:  B M Yashodhara; Choo Beng Huat; Lakshmi Nagappa Naik; Shashikiran Umakanth; Manjunatha Hande; Joseph M Pappachan
Journal:  Infect Drug Resist       Date:  2010-10-22       Impact factor: 4.003

2.  Survival of drug resistant tuberculosis patients in Lithuania: retrospective national cohort study.

Authors:  Yanina Balabanova; Birute Radiulyte; Edita Davidaviciene; Richard Hooper; Olga Ignatyeva; Vladyslav Nikolayevskyy; Francis A Drobniewski
Journal:  BMJ Open       Date:  2011-11-28       Impact factor: 2.692

3.  First-line tuberculosis drug resistance patterns and associated risk factors in Germany, 2008-2017.

Authors:  Saskia Glasauer; Doris Altmann; Barbara Hauer; Bonita Brodhun; Walter Haas; Nita Perumal
Journal:  PLoS One       Date:  2019-06-12       Impact factor: 3.240

Review 4.  Tuberculosis treatment outcome monitoring in European Union countries: systematic review.

Authors:  Rob van Hest; Csaba Ködmön; Suzanne Verver; Connie G M Erkens; Masja Straetemans; Davide Manissero; Gerard de Vries
Journal:  Eur Respir J       Date:  2012-07-12       Impact factor: 16.671

5.  Factors associated with unreported tuberculosis cases in Spanish hospitals.

Authors:  Concepción Morales-García; Teresa Rodrigo; Marta M García-Clemente; Ana Muñoz; Pilar Bermúdez; Francisco Casas; María Somoza; Celia Milá; Antón Penas; Carmen Hidalgo; Martí Casals; Joan A Caylá
Journal:  BMC Infect Dis       Date:  2015-07-29       Impact factor: 3.090

6.  Comparing microspheres with different internal phase of polyelectrolyte as local drug delivery system for bone tuberculosis therapy.

Authors:  Gang Wu; Long Chen; Hong Li; Chun-Ling Deng; Xiao-Feng Chen
Journal:  Biomed Res Int       Date:  2014-02-23       Impact factor: 3.411
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.